A detailed history of Two Sigma Investments, LP transactions in Chimerix Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 24,726 shares of CMRX stock, worth $21,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,726
Previous 29,278 15.55%
Holding current value
$21,758
Previous $25,000 12.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.77 - $1.07 $3,505 - $4,870
-4,552 Reduced 15.55%
24,726 $22,000
Q2 2024

Aug 14, 2024

SELL
$0.87 - $1.05 $17,254 - $20,824
-19,833 Reduced 40.38%
29,278 $25,000
Q1 2024

May 15, 2024

BUY
$0.91 - $1.26 $34,408 - $47,641
37,811 Added 334.61%
49,111 $52,000
Q4 2023

Feb 14, 2024

BUY
$0.9 - $1.06 $10,170 - $11,978
11,300 New
11,300 $10,000
Q2 2023

Aug 14, 2023

SELL
$1.1 - $1.54 $16,054 - $22,476
-14,595 Reduced 32.95%
29,703 $35,000
Q1 2023

May 15, 2023

SELL
$1.19 - $2.09 $687,403 - $1.21 Million
-577,650 Reduced 92.88%
44,298 $55,000
Q4 2022

Feb 14, 2023

BUY
$1.67 - $2.35 $135,393 - $190,523
81,074 Added 14.99%
621,948 $1.16 Million
Q3 2022

Nov 14, 2022

BUY
$1.81 - $2.76 $852,967 - $1.3 Million
471,253 Added 676.88%
540,874 $1.04 Million
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $93,292 - $371,776
69,621 New
69,621 $145,000
Q1 2022

May 16, 2022

SELL
$4.58 - $6.8 $111,294 - $165,240
-24,300 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$5.23 - $7.18 $4.46 Million - $6.13 Million
-853,123 Reduced 97.23%
24,300 $156,000
Q3 2021

Nov 15, 2021

SELL
$5.94 - $8.75 $139,952 - $206,158
-23,561 Reduced 2.62%
877,423 $5.43 Million
Q2 2021

Aug 16, 2021

BUY
$7.54 - $9.79 $2.69 Million - $3.5 Million
357,408 Added 65.75%
900,984 $7.21 Million
Q1 2021

May 17, 2021

SELL
$4.76 - $11.25 $347,094 - $820,338
-72,919 Reduced 11.83%
543,576 $5.24 Million
Q4 2020

Feb 16, 2021

SELL
$2.43 - $5.42 $66,961 - $149,353
-27,556 Reduced 4.28%
616,495 $2.98 Million
Q3 2020

Nov 16, 2020

SELL
$2.3 - $3.72 $177,677 - $287,373
-77,251 Reduced 10.71%
644,051 $1.6 Million
Q2 2020

Aug 14, 2020

BUY
$1.33 - $3.63 $243,820 - $665,466
183,324 Added 34.08%
721,302 $2.24 Million
Q1 2020

May 15, 2020

SELL
$1.27 - $2.33 $339,567 - $622,986
-267,376 Reduced 33.2%
537,978 $775,000
Q4 2019

Feb 14, 2020

BUY
$1.3 - $2.72 $494,172 - $1.03 Million
380,133 Added 89.4%
805,354 $1.64 Million
Q3 2019

Nov 14, 2019

BUY
$1.93 - $4.21 $264,467 - $576,896
137,030 Added 47.55%
425,221 $999,000
Q2 2019

Aug 14, 2019

SELL
$2.05 - $4.32 $283,355 - $597,119
-138,222 Reduced 32.42%
288,191 $1.25 Million
Q1 2019

May 15, 2019

BUY
$1.79 - $3.12 $210,648 - $367,164
117,681 Added 38.12%
426,413 $895,000
Q4 2018

Feb 14, 2019

BUY
$2.24 - $3.9 $239,120 - $416,325
106,750 Added 52.85%
308,732 $793,000
Q3 2018

Nov 14, 2018

BUY
$3.58 - $4.9 $723,095 - $989,711
201,982 New
201,982 $786,000
Q2 2018

Aug 14, 2018

SELL
$4.43 - $5.14 $719,250 - $834,525
-162,359 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$4.65 - $5.9 $288,672 - $366,272
-62,080 Reduced 27.66%
162,359 $844,000
Q4 2017

Feb 14, 2018

BUY
$4.32 - $5.52 $451,781 - $577,276
104,579 Added 87.25%
224,439 $1.04 Million
Q3 2017

Nov 14, 2017

BUY
$4.35 - $5.25 $521,390 - $629,265
119,860
119,860 $629,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.